Blocking agents of the adrenoceptors alpha 1/alpha 2 are typically used to treat the effects of the vasoconstriction associated with vascular<unk> . Cilostazol (trade name: Pletal) is FDA approved for intermittent<unk> . It is contraindicated in patients with heart failure, and improvement of symptoms may not be evident for two to three weeks. Neurogenic<unk>  can be treated surgically with spinal decompression.
Claudication
Cavitation 
Chest pain
Palisade 
Palpitations
Edema
Xiphodynia
Cardiomegaly